Literature DB >> 19367030

Impact of hyperglycemic control on left ventricular myocardium. A molecular and cellular basic study in a diabetic rat model.

Pei-Hsun Sung1, Cheuk-Kwan Sun, Sheung-Fat Ko, Li-Teh Chang, Jiunn-Jye Sheu, Fan-Yen Lee, Chiung-Jen Wu, Sarah Chua, Hon-Kan Yip.   

Abstract

This experimental study investigated the impact of hyperglycemic control on left ventricular (LV) function using a model of diabetes mellitus (DM) (induced by streptozocin 60 mg/kg). Sixteen adult-Sprague Dawley rats were divided into group 1 (poor hyperglycemic control, n = 8) and group 2 (good hyperglycemic control, n = 8). Diabetic rats and 8 healthy rats serving as controls (group 3) were sacrificed on day 28 after DM induction. The results demonstrated that HbA(1C) on day 28 was higher in group 1 than in groups 2 and 3 (P < 0.0001). The mRNA expressions of MMP-9 and endothelin-1 were elevated in group 1 compared with that in groups 2 and 3 (P < 0.05), whereas PGC-1alpha and eNOS were lower in group 1 than in groups 2 and 3 (P < 0.05). The number of apoptotic nuclei was higher in group 1 than in groups 2 and 3 (P < 0.01). The integrated area (microm(2)) of connexin43 (Cx43), Cx43 protein expression, and LV function were lower in group 1 than in groups 2 and 3 (P < 0.05). Moreover, PKC-epsilon expression in the mitochondrial compartment was decreased in group 1 compared to that in groups 2 and 3 (P < 0.005).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19367030     DOI: 10.1536/ihj.50.191

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  7 in total

1.  Alterations in connexin 43 during diabetic cardiomyopathy: competition of tyrosine nitration versus phosphorylation.

Authors:  Mandar S Joshi; Michael J Mihm; Angela C Cook; Brandon L Schanbacher; John Anthony Bauer
Journal:  J Diabetes       Date:  2014-07-15       Impact factor: 4.006

2.  The Therapeutic Role of Slit2 in Anti-fibrosis, Anti-inflammation and Anti-oxidative Stress in Rats with Coronary Heart Disease.

Authors:  Ji-Wei Liu; Hai-Tao Liu; Lin Chen
Journal:  Cardiovasc Toxicol       Date:  2021-08-19       Impact factor: 3.231

3.  Extracorporeal shock wave therapy effectively prevented diabetic neuropathy.

Authors:  Yi-Ling Chen; Kuan-Hung Chen; Tsung-Cheng Yin; Tien-Hung Huang; Chun-Man Yuen; Sheng-Ying Chung; Pei-Hsun Sung; Meng-Shen Tong; Chih-Hung Chen; Hsueh-Wen Chang; Kun-Chen Lin; Sheung-Fat Ko; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

4.  Effect of obesity reduction on preservation of heart function and attenuation of left ventricular remodeling, oxidative stress and inflammation in obese mice.

Authors:  Hui-Ting Wang; Chu-Feng Liu; Tzu-Hsien Tsai; Yung-Lung Chen; Hsueh-Wen Chang; Ching-Yen Tsai; Steve Leu; Yen-Yi Zhen; Han-Tan Chai; Sheng-Ying Chung; Sarah Chua; Chia-Hung Yen; Hon-Kan Yip
Journal:  J Transl Med       Date:  2012-07-11       Impact factor: 5.531

5.  Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat.

Authors:  Fanna Liu; Hon-Kan Yip; Ya Yue; Jui-Ning Yeh; John Y Chiang; Pei-Hsun Sung; Yi-Ling Chen
Journal:  Stem Cell Res Ther       Date:  2022-05-07       Impact factor: 8.079

6.  Double overexpression of miR-19a and miR-20a in induced pluripotent stem cell-derived mesenchymal stem cells effectively preserves the left ventricular function in dilated cardiomyopathic rat.

Authors:  Jiunn-Jye Sheu; Han-Tan Chai; Pei-Hsun Sung; John Y Chiang; Tien-Hung Huang; Pei-Lin Shao; Shun-Cheng Wu; Hon-Kan Yip
Journal:  Stem Cell Res Ther       Date:  2021-06-29       Impact factor: 6.832

7.  Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats.

Authors:  Sarah Chua; Fan-Yen Lee; Tzu-Hsien Tsai; Jiunn-Jye Sheu; Steve Leu; Cheuk-Kwan Sun; Yung-Lung Chen; Hsueh-Wen Chang; Han-Tan Chai; Chu-Feng Liu; Hung-I Lu; Hon-Kan Yip
Journal:  J Transl Med       Date:  2014-12-13       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.